The mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 4, 2015, Pages 2328-2336

  Danilchanka, Olga ^a,c   Pires, David ^b   Anes, Elsa ^b   Niederweis, Michael ^a  

^a University of Alabama at Birmingham   (United States)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AMPICILLIN; BACTERIAL PROTEIN; CLARITHROMYCIN; CPNT PROTEIN; ETHAMBUTOL; GLYCEROL; INTERLEUKIN 1BETA; ISONIAZID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; OUTER MEMBRANE PROTEIN; RV3903 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL SURVIVAL; GENE MUTATION; HUMAN; HUMAN CELL; HYDROPHILICITY; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; MEMBRANE PERMEABILITY; MOUSE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUTRIENT UPTAKE; OPTICAL DENSITY; PERMEABILITY BARRIER; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENETICS; MACROPHAGE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TOXINS; CELL LINE; DRUG RESISTANCE, BACTERIAL; HUMANS; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 84928902229     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04222-14     Document Type: Article

References (64)

1. World Health Organization. 2013. Global tuberculosis control: WHO report 2012. World Health Organization, Geneva, Switzerland.
2. Udwadia ZF. 2012. MDR, XDR, TDR tuberculosis: ominous progression. Thorax 67:286-288. http://dx.doi.org/10.1136/thoraxjnl-2012-201663.
3. Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Migliori GB, Warren R. 2014. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2:321-338. http://dx.doi.org/10.1016/S2213-2600(14)70031-1.
4. Blanchard JS. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu Rev Biochem 65:215-239. http://dx.doi.org/10.1146/annurev.bi.65.070196.001243.
5. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13:1320-1330.
6. Zhang H, Li D, Zhao L, Fleming J, Lin N, Wang T, Liu Z, Li C, Galwey N, Deng J, Zhou Y, Zhu Y, Gao Y, Wang T, Wang S, Huang Y, Wang M, Zhong Q, Zhou L, Chen T, Zhou J, Yang R, Zhu G, Hang H, Zhang J, Li F, Wan K, Wang J, Zhang XE, Bi L. 2013. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 45:1255-1260. http://dx.doi.org/10.1038/ng.2735.
7. Goldberg DE, Siliciano RF, Jacobs WR, Jr. 2012. Outwitting evolution: fighting drug-resistant TB, malaria, and HIV. Cell 148:1271-1283. http://dx.doi.org/10.1016/j.cell.2012.02.021.
8. Brennan PJ, Nikaido H. 1995. The envelope of mycobacteria. Annu Rev Biochem 64:29-63. http://dx.doi.org/10.1146/annurev.bi.64.070195.000333.
9. Nikaido H. 2001. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 12:215-223. http://dx.doi.org/10.1006/scdb.2000.0247.
10. da Silva PE, Von Groll A, Martin A, Palomino JC. 2011. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 63:1-9. http://dx.doi.org/10.1111/j.1574-695X.2011.00831.x.
11. Rodrigues L, Ainsa JA, Amaral L, Viveiros M. 2011. Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors. Recent Patents Anti-Infect Drug Discov 6:118-127. http://dx.doi.org/10.2174/157489111796064579.
12. Niederweis M. 2008. Nutrient acquisition by mycobacteria. Microbiology 154:679-692. http://dx.doi.org/10.1099/mic.0.2007/012872-0.
13. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. 2011. The challenge of new drug discovery for tuberculosis. Nature 469:483-490. http://dx.doi.org/10.1038/nature09657.
14. Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H. 2008. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci U S A 105:3963-3967. http://dx.doi.org/10.1073/pnas.0709530105.
15. Niederweis M, Danilchanka O, Huff J, Hoffmann C, Engelhardt H. 2010. Mycobacterial outer membranes: in search of proteins. Trends Microbiol 18:109-116. http://dx.doi.org/10.1016/j.tim.2009.12.005.
16. Sani M, Houben EN, Geurtsen J, Pierson J, de Punder K, van Zon M, Wever B, Piersma SR, Jimenez CR, Daffe M, Appelmelk BJ, Bitter W, van der Wel N, Peters PJ. 2010. Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog 6:e1000794. http://dx.doi.org/10.1371/journal.ppat.1000794.
17. Barry CE. 2001. Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. Trends Microbiol 9:237-241. http://dx.doi.org/10.1016/S0966-842X(01)02018-2.
18. Zeth K, Thein M. 2010. Porins in prokaryotes and eukaryotes: common themes and variations. Biochem J 431:13-22. http://dx.doi.org/10.1042/BJ20100371.
19. Nikaido H, Rosenberg EY. 1983. Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J Bacteriol 153: 241-252.
20. Pages JM, James CE, Winterhalter M. 2008. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 6:893-903. http://dx.doi.org/10.1038/nrmicro1994.
21. Kartmann B, Stenger S, Niederweis M. 1999. Porins in the cell wall of Mycobacterium tuberculosis. J Bacteriol 181:6543-6546. (Author correction, 181:7650.)
22. Lichtinger T, Heym B, Maier E, Eichner H, Cole ST, Benz R. 1999. Evidence for a small anion-selective channel in the cell wall of Mycobacterium bovis BCG besides a wide cation-selective pore. FEBS Lett 454:349-355. http://dx.doi.org/10.1016/S0014-5793(99)00844-3.
23. Niederweis M. 2008. Mycobacterial porins, p 153-165. In Daffe M, Reyrat J-M (ed), The mycobacterial cell envelope. ASM Press, Washington, DC.
24. Faller M, Niederweis M, Schulz GE. 2004. The structure of a mycobacterial outer-membrane channel. Science 303:1189-1192. http://dx.doi.org/10.1126/science.1094114.
25. Feltcher ME, Gibbons HS, Ligon LS, Braunstein M. 2012. Protein export by the mycobacterial SecA2 system is determined by the preprotein mature domain. J Bacteriol 195:672-681. http://dx.doi.org/10.1128/JB.02032-12.
26. Bansal-Mutalik R, Nikaido H. 2011. Quantitative lipid composition of cell envelopes of Corynebacterium glutamicum elucidated through reverse micelle extraction. Proc Natl Acad Sci U S A 108:15360-15365. http://dx.doi.org/10.1073/pnas.1112572108.
27. Rezwan M, Laneelle MA, Sander P, Daffe M. 2007. Breaking down the wall: fractionation of mycobacteria. J Microbiol Methods 68:32-39. http://dx.doi.org/10.1016/j.mimet.2006.05.016.
28. Stahl C, Kubetzko S, Kaps I, Seeber S, Engelhardt H, Niederweis M. 2001. MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis. Mol Microbiol 40:451-464 http://dx.doi.org/10.1046/j.1365-2958.2001.02394.x. (Author correction, Mol Microbiol 57:1509.)
29. Stephan J, Bender J, Wolschendorf F, Hoffmann C, Roth E, Mailänder C, Engelhardt H, Niederweis M. 2005. The growth rate of Mycobacterium smegmatis depends on sufficient porin-mediated influx of nutrients. Mol Microbiol 58:714-730. http://dx.doi.org/10.1111/j.1365-2958.2005.04878.x.
30. Mailaender C, Reiling N, Engelhardt H, Bossmann S, Ehlers S, Niederweis M. 2004. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis. Microbiology 150:853-864. http://dx.doi.org/10.1099/mic.0.26902-0.
31. Danilchanka O, Sun J, Pavlenok M, Maueroder C, Speer A, Siroy A, Marrero J, Trujillo C, Mayhew DL, Doornbos KS, Munoz LE, Herrmann M, Ehrt S, Berens C, Niederweis M. 2014. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc Natl Acad Sci U S A 111:6750-6755. http://dx.doi.org/10.1073/pnas.1400136111.
32. Leyton DL, Rossiter AE, Henderson IR. 2012. From self sufficiency to dependence: mechanisms and factors important for autotransporter biogenesis. Nat Rev Microbiol 10:213-225. http://dx.doi.org/10.1038/nrmicro2733.
33. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36:362-366.
34. Danilchanka O, Mailaender C, Niederweis M. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob Agents Chemother 52:2503-2511. http://dx.doi.org/10.1128/AAC.00298-08.
35. Danilchanka O, Pavlenok M, Niederweis M. 2008. Role of porins for uptake of antibiotics by Mycobacterium smegmatis. Antimicrob Agents Chemother 52:3127-3134. http://dx.doi.org/10.1128/AAC.00239-08.
36. Mojib N, Philpott R, Huang JP, Niederweis M, Bej AK. 2010. Antimycobacterial activity in vitro of pigments isolated from Antarctic bacteria. Antonie Van Leeuwenhoek 98:531-540. http://dx.doi.org/10.1007/s10482-010-9470-0.
37. Jordao L, Bleck CK, Mayorga L, Griffiths G, Anes E. 2008. On the killing of mycobacteria by macrophages. Cell Microbiol 10:529-548. http://dx.doi.org/10.1111/j.1462-5822.2007.01067.x.
38. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593-656. http://dx.doi.org/10.1128/MMBR.67.4.593-656.2003.
39. Stephan J, Mailaender C, Etienne G, Daffe M, Niederweis M. 2004. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother 48:4163-4170. http://dx.doi.org/10.1128/AAC.48.11.4163-4170.2004.
40. MacMicking J, Xie QW, Nathan C. 1997. Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350. http://dx.doi.org/10.1146/annurev.immunol.15.1.323.
41. Fabrino DL, Bleck CK, Anes E, Hasilik A, Melo RC, Niederweis M, Griffiths G, Gutierrez MG. 2009. Porins facilitate nitric oxide-mediated killing of mycobacteria. Microbes Infect 11:868-875. http://dx.doi.org/10.1016/j.micinf.2009.05.007.
42. Herrera M, Hong NJ, Garvin JL. 2006. Aquaporin-1 transports NO across cell membranes. Hypertension 48:157-164. http://dx.doi.org/10.1161/01.HYP.0000223652.29338.77.
43. Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS. 2012. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 11:469-480. http://dx.doi.org/10.1016/j.chom.2012.03.007.
44. Simeone R, Bobard A, Lippmann J, Bitter W, Majlessi L, Brosch R, Enninga J. 2012. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog 8:e1002507. http://dx.doi.org/10.1371/journal.ppat.1002507.
45. McDonough KA, Kress Y. 1995. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun 63:4802-4811.
46. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, Marks CB, Padiyar J, Goulding C, Gingery M, Eisenberg D, Russell RG, Derrick SC, Collins FM, Morris SL, King CH, Jacobs WR, Jr. 2003. The primary mechanism of attenuation of Bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A 100:12420-12425. http://dx.doi.org/10.1073/pnas.1635213100.
47. Kuusi N, Nurminen M, Saxen H, Makela PH. 1981. Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide. Infect Immun 34:328-332.
48. Tabaraie B, Sharma BK, Sharma PR, Sehgal R, Ganguly NK. 1994. Evaluation of Salmonella porins as a broad spectrum vaccine candidate. Microbiol Immunol 38:553-559. http://dx.doi.org/10.1111/j.1348-0421.1994.tb01822.x.
49. Vordermeier HM, Drexler H, Bessler WG. 1987. Polyclonal activation of human peripheral blood lymphocytes by bacterial porins and defined porin fragments. Immunol Lett 15:121-126. http://dx.doi.org/10.1016/0165-2478(87)90042-3.
50. Galdiero F, de L'ero GC, Benedetto N, Galdiero M, Tufano MA. 1993. Release of cytokines induced by Salmonella typhimurium porins. Infect Immun 61:155-161.
51. Mishra BB, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, Moita LF, Anes E. 2010. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 12: 1046-1063. http://dx.doi.org/10.1111/j.1462-5822.2010.01450.x.
52. Mishra BB, Rathinam VA, Martens GW, Martinot AJ, Kornfeld H, Fitzgerald KA, Sassetti CM. 2013. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta. Nat Immunol 14:52-60. http://dx.doi.org/10.1038/ni.2474.
53. Jarlier V, Nikaido H. 1994. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123:11-18. http://dx.doi.org/10.1111/j.1574-6968.1994.tb07194.x.
54. Niederweis M. 2003. Mycobacterial porins-new channel proteins in unique outer membranes. Mol Microbiol 49:1167-1177. http://dx.doi.org/10.1046/j.1365-2958.2003.03662.x.
55. Delcour AH. 2009. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794:808-816. http://dx.doi.org/10.1016/j.bbapap.2008.11.005.
56. Bond PJ, Sansom MS. 2007. Bilayer deformation by the Kv channel voltage sensor domain revealed by self-assembly simulations. Proc Natl Acad Sci U S A 104:2631-2636. http://dx.doi.org/10.1073/pnas.0606822104.
57. Rodriguez-Ropero F, Fioroni M. 2012. Structural and dynamical analysis of an engineered FhuA channel protein embedded into a lipid bilayer or a detergent belt. J Struct Biol 177:291-301. http://dx.doi.org/10.1016/j.jsb.2011.12.021.
58. Cortes T, Schubert OT, Rose G, Arnvig KB, Comas I, Aebersold R, Young DB. 2013. Genome-wide mapping of transcriptional start sites defines an extensive leaderless transcriptome in Mycobacterium tuberculosis. Cell Rep 5:1121-1131. http://dx.doi.org/10.1016/j.celrep.2013.10.031.
59. Brosch R, Pym AS, Gordon SV, Cole ST. 2001. The evolution of mycobacterial pathogenicity: clues from comparative genomics. Trends Microbiol 9:452-458. http://dx.doi.org/10.1016/S0966-842X(01)02131-X.
60. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, Garnier T, Gutierrez C, Hewinson G, Kremer K, Parsons LM, Pym AS, Samper S, van Soolingen D, Cole ST. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99:3684-3689. http://dx.doi.org/10.1073/pnas.052548299.
61. Borrell S, Gagneux S. 2011. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 17: 815-820. http://dx.doi.org/10.1111/j.1469-0691.2011.03556.x.
62. Louw GE, Warren RM, Gey van Pittius NC, McEvoy CR, Van Helden PD, Victor TC. 2009. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother 53:3181-3189. http://dx.doi.org/10.1128/AAC.01577-08.
63. Purdy GE, Niederweis M, Russell DG. 2009. Decreased outer membrane permeability protects mycobacteria from killing by ubiquitin-derived peptides. Mol Microbiol 73:844-857. http://dx.doi.org/10.1111/j.1365-2958.2009.06801.x.
64. Kessel M, Brennan MJ, Trus BL, Bisher ME, Steven AC. 1988. Naturally crystalline porin in the outer membrane of Bordetella pertussis. J Mol Biol 203:275-278. http://dx.doi.org/10.1016/0022-2836(88)90108-8.